Not MiSeq Beaters

There was a recent post on GenomeWeb, suggesting that a number of players were coming out with kits and instruments that “offer a challenge to Illumina's dominance at this lower end of the sequencing market, especially the MiSeq”.

But what’s actually presented, doesn’t seem to provide much of a challenge to the MiSeq.